Kura Oncology KURA Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's total current liabilities?
- Kura Oncology (KURA) reported total current liabilities of $101.5M in Q1 2026.
- How has Kura Oncology's total current liabilities changed year-over-year?
- Kura Oncology's total current liabilities increased by 13.1% year-over-year, from $89.77M to $101.5M.
- What is the long-term trend for Kura Oncology's total current liabilities?
- Over 5 years (2020 to 2025), Kura Oncology's total current liabilities has grown at a 35.1% compound annual growth rate (CAGR), from $26.02M to $116.97M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.